SEQUENCE VARIATION IN THE APOA2 GENE AND ITS RELATIONSHIP WITH PLASMA HDL-CHOLESTEROL LEVELS

作者: Sally Marie Hollister

DOI:

关键词: Genetic associationCandidate geneBiologyGeneticsAlleleSNP genotypingHigh-density lipoproteinGenetic variationHeritabilityGenotyping

摘要: Coronary heart disease (CHD) is a major public health concern, affecting almost 16 million people in the U.S. and leading to 452,300 deaths 2004 alone. Low levels of high density lipoprotein (HDL) cholesterol have been shown increase risk for cardiovascular (CVD). The role genetics total cholesterol, HDL-cholesterol, triglycerides significant, with heritability estimates exceeding 50%. Recent studies identified loci associated HDL-cholesterol through genome-wide association studies, which investigated influences common variants on traits. Relatively few impact rare (or modest affect) disease. aim our study was evaluate genetic variation APOA2 (a biological candidate gene involved HDL metabolism) relation epidemiological samples African Blacks Non-Hispanic Whites (NHWs). We resequenced individuals upper 5th percentile (47 NHWs 48 Blacks) lower (48 47 Blacks), allowing us identify both variants. Common tagSNPs all screened larger NHW Black associations levels. detected 26 (25 single nucleotide substitutions 1 microsatellite); 12 were previously unreported. Of new variants, 6 present Blacks. observed an increased number minor alleles (either heterozygosity or homozygosity variants) subjects low levels, more pronounced NHWs. performed preliminary analysis using 9 that (n=624, 8 (n=788, 5 TaqMan SNP genotyping assays date. For NHWs, we found significant only females 2233C>T/rs6413453 (p=0.028) 3251A>G (p=0.023). Completing remaining will allow determine extent influence

参考文章(69)
Uri Goldbourt, Shlomit Yaari, Jack H. Medalie, Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality A 21-Year Follow-up of 8000 Men Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 17, pp. 107- 113 ,(1997) , 10.1161/01.ATV.17.1.107
Nosratola D. Vaziri, Molecular mechanisms of lipid disorders in nephrotic syndrome Kidney International. ,vol. 63, pp. 1964- 1976 ,(2003) , 10.1046/J.1523-1755.2003.00941.X
Daniel Wüstner, Frederick R. Maxfield, Intracellular cholesterol transport Journal of Clinical Investigation. ,vol. 110, pp. 891- 898 ,(2002) , 10.1172/JCI16500
Alfredo Morabia, Eftihia Cayanis, Michael C Costanza, Barbara M Ross, Maria Sol Flaherty, Gabriela B Alvin, Kamna Das, T Conrad Gilliam, Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors Human Molecular Genetics. ,vol. 12, pp. 2733- 2743 ,(2003) , 10.1093/HMG/DDG314
H. B. Brewer, S. E. Lux, R. Ronan, K. M. John, Amino Acid Sequence of Human apoLp-Gln-II (apoA-II), an Apolipoprotein Isolated from the High-Density Lipoprotein Complex Proceedings of the National Academy of Sciences of the United States of America. ,vol. 69, pp. 1304- 1308 ,(1972) , 10.1073/PNAS.69.5.1304
Stephen J. Nicholls, E. Murat Tuzcu, Ilke Sipahi, Adam W. Grasso, Paul Schoenhagen, Tingfei Hu, Kathy Wolski, Tim Crowe, Milind Y. Desai, Stanley L. Hazen, Samir R. Kapadia, Steven E. Nissen, Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis JAMA. ,vol. 297, pp. 499- 508 ,(2007) , 10.1001/JAMA.297.5.499
N Vu-Dac, K Schoonjans, V Kosykh, J Dallongeville, R A Heyman, B Staels, J Auwerx, Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor Molecular and Cellular Biology. ,vol. 16, pp. 3350- 3360 ,(1996) , 10.1128/MCB.16.7.3350
TL Eggerman, JM Hoeg, MS Meng, A Tombragel, D Bojanovski, HB Brewer, Differential tissue-specific expression of human apoA-I and apoA-II Journal of Lipid Research. ,vol. 32, pp. 821- 828 ,(1991) , 10.1016/S0022-2275(20)42034-6